Market Watch: CryoPort Inc (CYRX)’s Noteworthy Gain, Closing at 7.87

Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

As of close of business last night, CryoPort Inc’s stock clocked out at $7.87, up 2.34% from its previous closing price of $7.69. In other words, the price has increased by $2.34 from its previous closing price. On the day, 90755.0 shares were traded. CYRX stock price reached its highest trading level at $7.88 during the session, while it also had its lowest trading level at $7.42.

Ratios:

To gain a deeper understanding of CYRX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.32 and its Current Ratio is at 5.70. In the meantime, Its Debt-to-Equity ratio is 0.56 whereas as Long-Term Debt/Eq ratio is at 0.51.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Guggenheim on December 19, 2024, initiated with a Buy rating and assigned the stock a target price of $11.

On August 07, 2024, Jefferies Downgraded its rating to Hold which previously was Buy and also lowered its target price recommendation from $20 to $8.

B. Riley Securities Upgraded its Neutral to Buy on July 31, 2024, whereas the target price for the stock was revised from $19 to $15.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 02 ’24 when Mandalam Ramkumar sold 7,369 shares for $7.46 per share. The transaction valued at 54,978 led to the insider holds 59,497 shares of the business.

Hariri Robert J sold 2,500 shares of CYRX for $16,200 on Nov 21 ’24. The Director now owns 20,561 shares after completing the transaction at $6.48 per share. On Dec 02 ’24, another insider, RAMKUMAR MANDALAM, who serves as the Director of the company, bought 7,369 shares for $7.08 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CYRX now has a Market Capitalization of 389018816 and an Enterprise Value of 381499392. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.72 while its Price-to-Book (P/B) ratio in mrq is 1.01. Its current Enterprise Value per Revenue stands at 1.687 whereas that against EBITDA is -9.687.

Stock Price History:

Over the past 52 weeks, CYRX has reached a high of $20.10, while it has fallen to a 52-week low of $5.32. The 50-Day Moving Average of the stock is 6.12%, while the 200-Day Moving Average is calculated to be -22.48%.

Shares Statistics:

It appears that CYRX traded 417.40K shares on average per day over the past three months and 326390 shares per day over the past ten days. A total of 49.43M shares are outstanding, with a floating share count of 47.59M. Insiders hold about 3.72% of the company’s shares, while institutions hold 95.50% stake in the company. Shares short for CYRX as of 1732838400 were 2501805 with a Short Ratio of 5.99, compared to 1730332800 on 2908718. Therefore, it implies a Short% of Shares Outstanding of 2501805 and a Short% of Float of 6.0900003.

Most Popular